Global plant tissue analysis market is estimated to be valued at US$ 228.2 million in 2023 and is expected to exhibit a CAGR of 4.7% during the forecast period (2023-2030). Increasing approval of plant-based vaccines by the regulatory authorities is expected to assist in the growth of the market over the forecast period. For instance, in 2022, Medicago, the Quebec-based pharmaceutical company, announced that it had received approval for the first plant-based COVID-19 vaccine for use in adults aged 18 to 64, from Health Canada, the Department of the Government of Canada responsible for Canada’s national health policy
Plant Tissue Analysis Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients